Back to Journals » Patient Preference and Adherence » Volume 2

Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review

Authors Graziottin A

Published 23 November 2008 Volume 2008:2 Pages 357—367


Review by Single-blind

Peer reviewer comments 4

Alessandra Graziottin

Center of Gynecology and Medical Sexology, H San Raffaele Resnati, Via Santa Croce 10/a, 20123 Milano, Italy

Abstract: The worldwide introduction of the first, unique patch for hormonal contraception (ethinyl estradiol/norelgestromin, EE/NGMN patch) was widely recognized as a significant event in the development of drug delivery systems. This innovation offers a number of advantages over the oral route, and extensive clinical trials have proved its safety, efficacy, effectiveness, and tolerability. The weekly administration and ease of use/simplicity of the EE/NGMN patch contribute to its acceptability, and help to resolve the two main problems of non-adherence, namely early discontinuation and inconsistent use. The patch offers additional benefits to adolescents (improvement of dysmenorrhea and acne), adults (improvement in emotional and physical well-being, premenstrual syndrome, and menstrual irregularities), and perimenopausal women (correction of hormonal imbalance, modulation of premenopausal symptoms), thus providing high satisfaction rates (in nearly 90% of users). Since its introduction, the transdermal contraceptive patch has proved to be a useful choice for women who seek a convenient formulation which is easy to use, with additional, non-contraceptive tailored benefits for all the ages.

Keywords: transdermal, hormonal contraceptive, patient satisfaction, patient adherence

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Retinal thickness after vitrectomy and internal limiting membrane peeling for macular hole and epiretinal membrane

Kumagai K, Ogino N, Furukawa M, Hangai M, Kazama S, Nishigaki S, Larson E

Clinical Ophthalmology 2012, 6:679-688

Published Date: 4 May 2012

Nitric oxide and coronary vascular endothelium adaptations in hypertension

Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al

Vascular Health and Risk Management 2009, 5:1075-1087

Published Date: 16 December 2009

Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy

Charlie Henri Viiala, John Kevin Olynyk

Patient Preference and Adherence 2008, 2:27-33

Published Date: 30 October 2008

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease

Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovich, Kathryn Fischbach, Justin C Shenk, et al

Vascular Health and Risk Management 2008, 4:721-730

Published Date: 6 June 2008

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain

Nicole Rae Yurgin, Kristina Secnik Boye, Tatiana Dilla, Núria Lara Suriñach, Xavier Badia Llach

Patient Preference and Adherence 2008, 2:87-95

Published Date: 8 April 2008

Medication adherence among heart and/or lung transplant recipients: An exploratory study

Rebecca A O’Brien, Parisa Aslani, Maria A Ciccia, Jo-anne E Brien

Patient Preference and Adherence 2008, 2:115-120

Published Date: 20 March 2008

Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France

Isabelle Ingrand, Sarah Dujoncquoy, Virginie Migeot, Véronique Ghadi, Michel Beauchant, Pierre Ingrand

Patient Preference and Adherence 2008, 2:47-55

Published Date: 13 March 2008

Cosmetic use of botulinum toxin type A in the elderly

Christine M Cheng

Clinical Interventions in Aging 2007, 2:81-83

Published Date: 15 April 2007